Home > Share Market > Stocks > Orchid pharma > Financial Statements > ORCHPHARMA Key Financial Ratios

Orchid pharma Financial Statements

Orchid pharma Key Financial Ratios

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar Mar-2022 Mar-2021 Mar-2020 Mar-2018
Growth matrix (%)        
Revenue growth 24.30 (11) (26) (14)
Op profit growth 6.71 (295) (262) (309)
EBIT growth (43) (65) 30.40 (20)
Net profit growth (98) (11) (63) (29)
Profitability ratios (%)        
OPM 9.50 11.10 (5) 2.30
EBIT margin (4.40) (9.80) (25) (14)
Net profit margin (0.30) (26) (26) (52)
RoCE (2.20) (3.10) (6.30) (3.70)
RoNW (0.10) (4.10) 254 14
RoA -- (2.10) (1.60) (3.40)
Per share ratios ()        
EPS 0.39 (29) (32) --
Dividend per share -- -- -- --
Cash EPS (22) (55) (63) (55)
Book value per share 159 160 188 (89)
Valuation ratios        
P/E 729 (86) -- --
P/CEPS (13) (45) -- (0.20)
P/B 1.79 15.40 -- (0.10)
EV/EBIDTA 22.90 161 -- 83.20
Payout (%)        
Dividend payout -- -- -- --
Tax payout -- -- -- (12)
Liquidity ratios        
Debtor days 99.90 82.60 67.30 75.90
Inventory days 106 119 120 108
Creditor days (100) (96) (157) (217)
Leverage ratios        
Interest coverage 0.78 0.86 30.50 0.32
Net debt / equity 0.40 0.66 0.51 (3.70)
Net debt / op. profit 4.89 8.69 (15) 185
Cost breakup ()        
Material costs (56) (51) (48) (51)
Employee costs (11) (15) (17) (13)
Other costs (23) (23) (40) (34)

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000